AstraZeneca Completes Enrollment in Phase III Non-Small Cell Lung Cancer Clinical Trial Program For IRESSA(R) (ZD1839)
(PR Newswire)...Clinical studies are ongoing regarding the use of IRESSA for other solid tumors.......The National Cancer Institute (NCI) or oncology cooperative groups are accruing patients into clinical trials with IRESSA in renal cell, bladder, glioblastoma and brain cancers.......Expression and overexpression of EGFR is found in many tumor types and clinical data suggests that excessive levels of EGFR are linked to poor prognosis,...- May 08 10:38 AM ET
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/prnews/010508/cgtu053.html
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines